AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771V958. A total of 2 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,000 | -97.2% | 100 | -50.0% | 0.00% | – |
| Q1 2021 | $36,000 | +200.0% | 200 | -80.0% | 0.00% | – |
| Q3 2020 | $12,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +400.0% | 1,000 | +400.0% | 0.00% | – |
| Q1 2020 | $3,000 | -84.2% | 200 | -75.0% | 0.00% | – |
| Q4 2019 | $19,000 | -98.6% | 800 | -98.9% | 0.00% | -100.0% |
| Q3 2019 | $1,365,000 | -38.2% | 71,000 | -5.1% | 0.01% | -45.0% |
| Q2 2019 | $2,210,000 | +90.2% | 74,800 | +132.3% | 0.02% | +100.0% |
| Q4 2018 | $1,162,000 | -41.4% | 32,200 | 0.0% | 0.01% | -37.5% |
| Q3 2018 | $1,982,000 | -44.2% | 32,200 | -38.8% | 0.02% | -46.7% |
| Q2 2018 | $3,553,000 | +455.2% | 52,600 | +345.8% | 0.03% | +400.0% |
| Q1 2018 | $640,000 | -54.2% | 11,800 | -49.6% | 0.01% | -40.0% |
| Q4 2017 | $1,398,000 | +106.8% | 23,400 | +68.3% | 0.01% | +66.7% |
| Q3 2017 | $676,000 | +69.4% | 13,900 | +82.9% | 0.01% | +50.0% |
| Q2 2017 | $399,000 | -88.3% | 7,600 | -89.9% | 0.00% | -90.0% |
| Q1 2017 | $3,406,000 | +448.5% | 75,100 | +357.9% | 0.04% | +566.7% |
| Q4 2016 | $621,000 | -78.7% | 16,400 | -78.7% | 0.01% | -81.2% |
| Q3 2016 | $2,910,000 | +24150.0% | 77,100 | +7610.0% | 0.03% | – |
| Q1 2016 | $12,000 | -97.1% | 1,000 | -94.2% | 0.00% | -100.0% |
| Q4 2015 | $419,000 | -79.1% | 17,200 | -84.8% | 0.01% | -82.1% |
| Q3 2015 | $2,003,000 | +140.5% | 112,900 | +139.2% | 0.03% | +133.3% |
| Q2 2015 | $833,000 | +3686.4% | 47,200 | +6642.9% | 0.01% | – |
| Q1 2015 | $22,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 74 | $99,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |